Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elagolix and E2/NETA for Endometriosis-Associated Pain
NCT03213457Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Jul 2017
- Primary completion
- Mar 2020
- Countries
- 3
01
Overview
A Phase 3 trial of elagolix in endometriosis, sponsored by AbbVie Inc.. Started Jul 2017; status: completed.
02
Drugs
elagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT03213457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03213457.